Bavarian Nordic A/S (OCSE:BAVA) Change In Receivables : kr-1,345 Mil (TTM As of Dec. 2023)

View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic A/S Change In Receivables?

Bavarian Nordic A/S's change in receivables for the quarter that ended in Dec. 2023 was kr-654 Mil. It means Bavarian Nordic A/S's Accounts Receivable increased by kr654 Mil from Sep. 2023 to Dec. 2023 .

Bavarian Nordic A/S's change in receivables for the fiscal year that ended in Dec. 2023 was kr-1,345 Mil. It means Bavarian Nordic A/S's Accounts Receivable increased by kr1,345 Mil from Dec. 2022 to Dec. 2023 .

Bavarian Nordic A/S's Accounts Receivable for the quarter that ended in Dec. 2023 was kr1,778 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Bavarian Nordic A/S's Days Sales Outstanding for the three months ended in Dec. 2023 was 66.30.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Bavarian Nordic A/S's liquidation value for the three months ended in Dec. 2023 was kr10 Mil.

Bavarian Nordic A/S Change In Receivables Historical Data

The historical data trend for Bavarian Nordic A/S's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic A/S Change In Receivables Chart

Bavarian Nordic A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

15.76

-88.09

-364.39

-133.17

-1,345.43

Bavarian Nordic A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															20.52	-266.12	-514.09	88.50	-653.72

Bavarian Nordic A/S Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1,345 Mil.

Bavarian Nordic A/S (OCSE:BAVA) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Bavarian Nordic A/S's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1778.104	/	2447.26	*	91
=	66.30

2. In Ben Graham's calculation of liquidation value, Bavarian Nordic A/S's accounts receivable are only considered to be worth 75% of book value:

Bavarian Nordic A/S's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1867.481	-	4013.281	+	0.75 * 1778.104	+	0.5 * 1643.736
=	10

Bavarian Nordic A/S Change In Receivables Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic A/S's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic A/S (OCSE:BAVA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic A/S (OCSE:BAVA) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

BVNRY:USA BVNKF:USA BAVAc:UK 0DPB:UK BV3:Germany

Address

Philip Heymans Alle 3, Hellerup, DNK, DK-2900

Website

https://www.bavarian-nordic.com

Bavarian Nordic A/S is a biotechnology company focused on the development, manufacturing, and commercialization of cancer immunotherapies and vaccines for infectious diseases. The company has a specific focus on diseases for which the unmet medical need is high. Bavarian generates revenue through government research and development and supply contracts, and from its commercial partnerships. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets.

Bavarian Nordic A/S (OCSE:BAVA) Headlines

No Headlines